1. Home
  2. SLGL vs GROV Comparison

SLGL vs GROV Comparison

Compare SLGL & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • GROV
  • Stock Information
  • Founded
  • SLGL 1997
  • GROV 2016
  • Country
  • SLGL Israel
  • GROV United States
  • Employees
  • SLGL N/A
  • GROV N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • GROV Package Goods/Cosmetics
  • Sector
  • SLGL Health Care
  • GROV Consumer Discretionary
  • Exchange
  • SLGL Nasdaq
  • GROV Nasdaq
  • Market Cap
  • SLGL 69.1M
  • GROV 64.0M
  • IPO Year
  • SLGL 2018
  • GROV N/A
  • Fundamental
  • Price
  • SLGL $33.66
  • GROV $1.34
  • Analyst Decision
  • SLGL Strong Buy
  • GROV Buy
  • Analyst Count
  • SLGL 1
  • GROV 2
  • Target Price
  • SLGL $50.00
  • GROV $1.35
  • AVG Volume (30 Days)
  • SLGL 11.7K
  • GROV 97.1K
  • Earning Date
  • SLGL 11-07-2025
  • GROV 11-13-2025
  • Dividend Yield
  • SLGL N/A
  • GROV N/A
  • EPS Growth
  • SLGL N/A
  • GROV N/A
  • EPS
  • SLGL N/A
  • GROV N/A
  • Revenue
  • SLGL $23,931,000.00
  • GROV $185,354,000.00
  • Revenue This Year
  • SLGL N/A
  • GROV N/A
  • Revenue Next Year
  • SLGL N/A
  • GROV $11.10
  • P/E Ratio
  • SLGL N/A
  • GROV N/A
  • Revenue Growth
  • SLGL 264.86
  • GROV N/A
  • 52 Week Low
  • SLGL $4.01
  • GROV $1.02
  • 52 Week High
  • SLGL $52.26
  • GROV $1.95
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 45.02
  • GROV 43.51
  • Support Level
  • SLGL $30.85
  • GROV $1.15
  • Resistance Level
  • SLGL $39.00
  • GROV $1.39
  • Average True Range (ATR)
  • SLGL 2.87
  • GROV 0.10
  • MACD
  • SLGL -1.25
  • GROV -0.01
  • Stochastic Oscillator
  • SLGL 22.17
  • GROV 45.24

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

Share on Social Networks: